Home
About
Overview
Sharing Data
ORCID
Help
History (21)
Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib.
Potential nonhormonal therapeutics for medical treatment of leiomyomas.
Impact of Antibiotic-Resistant Bacteria on Immune Activation and Clostridioides difficile Infection in the Mouse Intestine.
Neurophysiology of vestibular rehabilitation.
Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance.
See All 21 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance.
Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance. Genes Dis. 2015 Mar 01; 2(1):13-25.
View in:
PubMed
authors with profiles
Hue Luu